Navigation Links
Women's Testosterone Patch May Not Work
Date:3/2/2009

U.K. study also questions safety of drug Intrinsa used for sexual dysfunction

MONDAY, March 2 (HealthDay News) -- A new testosterone patch designed to boost a woman's sex drive may be ineffective, and questions remain about its long-term safety, according to the journal Drugs and Therapeutics Bulletin.

The drug Intrinsa was recently approved in the United Kingdom for treatment of women who've gone through menopause as the result of ovary and womb removal and who are receiving estrogen replacement therapy. There is some evidence that low levels of circulating testosterone may be linked to a decline in sex drive after menopause.

The patch, which is placed on the lower abdomen and delivers a daily dose of testosterone, is worn constantly and replaced twice weekly.

The journal noted, in finding that the patch may not work, that key clinical trials on testosterone patches involved highly selective groups of women. For example, the studies excluded those with various mental or physical conditions that could affect sex drive. In some trials, a hypoactive sexual desire disorder (HSDD) diagnosis was based on short, unvalidated questionnaires filled out by participants, the journal reported.

There were other problems with the studies:

  • There was a large placebo response. Significant numbers of women not treated with the patch reported improved sex drive, which suggests that low testosterone levels may not have been the problem.
  • Improvements in sex drive were small.
  • Many women were already having sex two or three times a month before they entered the trials, which raises questions about whether they really had poor sex drive in the first place.
  • The trials for Intrinsa lasted a maximum of six months, which means they didn't demonstrate the long-term safety of the patch.
  • Rates of side effects in the two key trials were around 75 percent. These included skin reactions at sites where the patches were applied, acne, excess hair, hair loss, breast pain, weight gain, insomnia , voice deepening, and migraine.

"The published evidence so far is based on highly selected women and only shows small improvements in sexual parameters and large placebo responses," according to the journal. "Also, the long-term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction."

More information

The National Women's Health Information Center has more about sexual health.



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, March 3, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Prostate cancer drug reduces testosterone levels in as little as 3 days
3. Study shows testosterone improves sexual well-being in post-menopausal women
4. Testosterone Patch Restores Libido in Postmenopausal Women
5. Testosterone key to disease transmission
6. AUDIO from Medialink and Solvay: Men Suffering From Symptoms of Low Testosterone Should Talk to Their Doctor
7. Studies Support Testosterone Supplements for Older Men
8. Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas
9. Men With Low Testosterone Not Receiving Treatment
10. Many men with low testosterone levels do not receive treatment
11. Testosterone Spray Improves Sexual Satisfaction in Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Women's Testosterone Patch May Not Work
(Date:7/20/2017)... ... July 20, 2017 , ... There’s a lot of confusing lingo out there ... the same thing. But it’s crucial to understand both the differences and similarities between ... Kaixuan Liu, MD, PhD, founder and president of Atlantic Spine Center . ...
(Date:7/20/2017)... ... , ... LINET, an international leader in healthcare technology and a global supplier ... birthing bed. , Perfectly suitable for labor, delivery, recovery and postpartum; the revolutionary design ... every phase of childbirth. The AVE 2 has many features that help make the ...
(Date:7/20/2017)... ... July 19, 2017 , ... Med Tech Solutions (MTS), a leading health ... business unit of Constellation Inc., a move that will help the company better serve ... St. Louis, the acquisition is expected to help MTS expand its presence ...
(Date:7/20/2017)... ... 2017 , ... A July 7th article on ... veins in some patients, according to medical experts. Washington State medical clinic Northwest ... sitting or standing, or regularly nicking yourself while shaving your legs, and taking ...
(Date:7/18/2017)... (PRWEB) , ... July 18, 2017 , ... ... device compliance and commercialization, has just announced two more sessions of its “From ... engineering into risk management activities. Led by David Cronin, Cognition’s CEO, the half-hour ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... July 11, 2017 Zymo Research Corp., also known as ,The ... quantify biological aging in a precise manner using the myDNAge ™ ... , a professor of human genetics and biostatistics at the David ... Public Health , Zymo Research,s proprietary DNAge ™ technology is used ... ...
(Date:7/11/2017)...  Dr. Echenberg, founder of Echenberg Institute, is announcing a new safe ... from painful intercourse and other painful pelvic pain conditions such as pelvic ... ... ... Florida -based start-up company, VuVatech LLC, fills a void in the ...
(Date:7/10/2017)... 10, 2017  BDI Group subsidiary Pathway Purchasing ... services organization serving specialty pharmacies, home infusion companies ... four significant, value-added member programs designed to help ... reimbursement and improve access and affordability for patients ... Pathway has ...
Breaking Medicine Technology: